已发表的部分文献: 标题:Social isolation-induced epigenetic changes in midbrain of adult mice.作者:Siuda D, Wu Z, Chen Y, Guo L, Linke M, Zechner U, Xia N, Reifenberg G, Kleinert H, Forstermann U, Li H;杂志名称:J Physiol Pharmacol 标题:Loss of NR2E3 represses AHR by LSD1 reprogramming, is associated with poor prognosis in liver cancer.作者:Khanal T, Choi K, Leung YK, Wang J, Kim D, Janakiram V, Cho SG, Puga A, Ho SM, Kim K;杂志名称:Sci Rep 标题:Molecular Basis for Transgenerational Toxicity Induction of Environmental Toxicants or Stresses作者:Wang D;杂志名称:Molecular Toxicology in Caenorhabditis elegans 标题:Reduction in H3K4me patterns due to aberrant expression of methyltransferases and demethylases in renal cell carcinoma: prognostic and therapeutic implications.作者:Kumar A, Kumari N, Sharma U, Ram S, Singh SK, Kakkar N, Kaushal K, Prasad R;杂志名称:Sci Rep Epigentek 公司是全球领先的表观遗传学相关研究的技术创新者和产品开发供应商。开发了超过700多个专利产品,为表观遗传学方面的研究和新药研发提供全面系统的解决方案,涵盖样品制备、DNA/RNA甲基化(5-mc, 5-hmc, 5-fc, m6A)/DNMT分析、ChIP、组蛋白甲基化/乙酰化/去乙酰化/磷酸化/SUMO-等领域,提供小分子抑制剂、蛋白质、抗体、以及分析试剂盒产品。